Detect

Detect, Inc., a Connecticut-based health technology company, is creating the next generation of at-home diagnostic tools to empower people to understand their health and make informed, timely decisions. Detect developed the Detect Covid-19 Test - an FDA approved, at- home PCR-quality test that provides accurate, convenient, and reliable results in about an hour.

AT A GLANCE

  • Category Confusion

  • Antigen vs. Molecular Test Options

  • Crowded Marketplace

  • Lack of Brand Awareness

CHALLENGES

SITUATION

Detect, Inc. was selected by the National Institutes of Health (NIH) for an $8.1 million grant to help fulfill national Covid-19 testing needs. The Detect Covid-19 Test was developed to provide consumers with an affordable at-home molecular test.

SOLUTIONS

Under tight deadlines and a product launch date set for less than six weeks the Amplicity Communications developed a strategic media outreach program to introduce Detect to both media and consumers. The PR strategy included:

  • Development of a media message guide for stakeholders

  • Drafting and coordinating press releases for wire release

  • Engaging media to attend press briefings & managing follow-up

  • Coordinating video and photo assets for an interactive media kit

  • Building strong relationships with key journalists

  • Outreaching to influencers and brand ambassadors

  • Securing media placements in top tier and secondary outlets

  • Garnering brand awareness for the product launch in a crowded marketplace

  • Positioning Detect spokespeople as thought leaders in the tech/health segment

Amplicity Communications played an integral role in supporting media briefings and managed media relations to position Detect as an innovative health technology company. Here, Detect founder, Dr. Jonathan Rothberg, CT Congresswoman Rosa DeLauro, and U.S. Senator Richard Blumenthal announce the latest funding and the next generation of Detect's at-home health diagnostic tools.

IMPACTFUL RESULTS

PUBLIC RELATIONS

NOCD

NOCD is the #1 telehealth platform for the treatment of OCD, the only online platform to offer Exposure and Response Prevention (ERP) therapy to individuals ages 5 and older with a commitment to properly diagnose and provide effective treatment to patients at an affordable cost. NOCD is accessible to 125 million people as a covered insurance benefit in all 50 United States, as well as outside of the United States.

AT A GLANCE

  • Shortage of therapists

  • Lack of effective OCD therapy options

  • Stigma surrounding mental health

CHALLENGES

SITUATION

NOCD secured partnerships with several healthcare coverage networks to help provide an affordable mental healthcare option to over 125 million Americans.

SOLUTIONS

Amplicity Communications developed a strategic media outreach program to introduce NOCD’s partnership. The PR strategy included:

  • Drafting and coordinating press releases for wire release

  • Engaging media to attend webinar event & managing follow-up

  • Building strong relationships with key journalists

  • Outreaching to influencers and brand ambassadors

  • Securing media placements in top tier and secondary outlets

  • Garnering brand awareness for the NOCD platform in a crowded marketplace

  • Positioning NOCD spokespeople as thought leaders in the tech/mental health segment

Amplicity Communications supported media outreach efforts and secured several placements in the media to educate and destigmatize mental health and empower people who struggle with mental illness to get the care they need.

IMPACTFUL RESULTS